TerminatedPhase 2NCT05667662
Study to Evaluate Itraconazole Administered as Inhaled Dry Powder in Adults With Asthma and ABPA
Studying Allergic bronchopulmonary aspergillosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Pulmatrix Inc.
- Principal Investigator
- Chris Cabell, MDPulmatrix Inc.
- Intervention
- Itraconazole Powder(drug)
- Enrollment
- 8 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2023 – 2024
Study locations (18)
- University of Alabama Medical Center at Birmingham, Birmingham, Alabama, United States
- Medical Research of Arizona, Scottsdale, Arizona, United States
- Jonathan Corren, MD, Santa Monica, California, United States
- Bensch Clinical Research, Stockton, California, United States
- Southern Illinois University Center for Clinical Research, Springfield, Illinois, United States
- University of Kansas Medical Center Research Institute, Kansas City, Kansas, United States
- Baylor University Medical Center, Dallas, Texas, United States
- UTMB Health, Galveston, Texas, United States
- Westmead Hospital, Westmead, New South Wales, Australia
- Mater Hospital Brisbane, Respiratory Research Group, South Brisbane, Queensland, Australia
- Royal Perth Hospital, Perth, Western Australia, Australia
- CHU Pontchaillou, Rennes, Cedex 9, France
- Nouvel Hôpital Civil, Strasbourg, Strasbourg Cedex, France
- CHU de Marseille Hôpital Nord, Marseille, France
- University Hospitals Birmingham - Heartlands Hospital, Birmingham, West Midlands, United Kingdom
- +3 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05667662 on ClinicalTrials.govOther trials for Allergic bronchopulmonary aspergillosis
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07362667A Study of the Efficacy and Safety of Bronchoscopic Airway Clearance and Amphotericin B Spraying in Patients With ABPAQianfoshan Hospital
- RECRUITINGNCT07362693A Cohort Study of the Efficacy and Safety of Biologics in Patients With ABPAQianfoshan Hospital
- RECRUITINGNCT07530770Real-World Effectiveness of Benralizumab in Allergic Bronchopulmonary AspergillosisQianfoshan Hospital
- RECRUITINGNCT07493629Immune Status and Disease Control of Inflammatory Airway DiseasesFirst Affiliated Hospital of Ningbo University
- RECRUITINGNCT07313904Effects of Environmental Fungal Exposure on Bronchial Asthma, ABPA and BronchiectasisFirst Affiliated Hospital of Ningbo University
- RECRUITINGNCT07040332Pathogenesis and Inflammatory Phenotype of Allergic Bronchopulmonary AspergillosisQianfoshan Hospital
- RECRUITINGPHASE2NCT06244979iMagIng pulmonaRy Aspergillosis Using Gallium-68-dEferoxamineRadboud University Medical Center
- RECRUITINGPHASE3NCT06174922A Randomized Trial of Prednisolone, Itraconazole, or Their Combination in Allergic Bronchopulmonary AspergillosisPost Graduate Institute of Medical Education and Research, Chandigarh
See all trials for Allergic bronchopulmonary aspergillosis →